Squarepoint
ETNB

Squarepoint’s 89bio ETNB Stock Holding History

Squarepoint’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,617
Closed -$93.4K – 5144
2024
Q3 		$93.4K Sell
12,617
-28,245
-69% -$237K ﹤0.01% 3887
2024
Q2 		$327K Buy
+40,862
New +$365K ﹤0.01% 3374
2023
Q3 		– Sell
-15,559
Closed -$295K – 3903
2023
Q2 		$295K Sell
15,559
-127,103
-89% -$2.23M ﹤0.01% 2982
2023
Q1 		$2.17M Buy
142,662
+103,076
+260% +$1.34M 0.01% 1369
2022
Q4 		$504K Buy
+39,586
New +$356K ﹤0.01% 2284
2022
Q3 		– Sell
-10,348
Closed -$33K – 3114
2022
Q2 		$33K Buy
+10,348
New +$31.2K ﹤0.01% 2743
2021
Q2 		– Sell
-17,527
Closed -$415K – 3359
2021
Q1 		$415K Sell
17,527
-22,543
-56% -$520K ﹤0.01% 2159
2020
Q4 		$977K Buy
40,070
+12,266
+44% +$314K 0.01% 1350
2020
Q3 		$713K Buy
+27,804
New +$882K 0.01% 1195

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Squarepoint's ETNB Position: Q4 2024 in Review

Squarepoint sold out of 89bio (ETNB) in Q4 2024, closing a stake of 12,617 shares — an estimated $93.4K sold.

Squarepoint first reported a position in ETNB in Q3 2020 and held it in 9 quarters. The position peaked at $2.17M in Q1 2023. 155 funds tracked by Wall St. Rank hold ETNB as of Q4 2024.

  • Squarepoint reported no remaining 89bio position as of Q4 2024 after selling out during the quarter.
  • Squarepoint sold 12,617 89bio shares in Q4 2024, an estimated $93.4K.
  • Squarepoint first reported a position in 89bio in Q3 2020 and held it in 9 quarters.
  • Squarepoint's 89bio position peaked at $2.17M in Q1 2023.
  • 155 funds tracked by Wall St. Rank held 89bio as of Q4 2024.

Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.